Retrieve available abstracts of 213 articles: HTML format
Single Articles
July 2025
TAN B, Webster H, Krishnaswamy S, MacPhail A, et al Outcomes of critical illness in peoples with Advanced HIV Disease: 30 years of
binational data.
Clin Infect Dis. 2025 Jul 4:ciaf362. doi: 10.1093. PubMedAbstract available
BROWN TT, Arao RF, Warsi M, Phanuphak N, et al Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil
Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women:
HPTN 083.
Clin Infect Dis. 2025 Jul 1:ciaf221. doi: 10.1093. PubMedAbstract available
June 2025
NYEIN PP, Borok M, Eriobu N, Kaplan R, et al A randomised trial to compare dolutegravir plus boosted darunavir versus
recommended standard of care antiretroviral regimens in people with HIV-1, whose
first-line non-nucleoside reverse transcriptase inhibitor therapy has failed:
Final 96-week resul
Clin Infect Dis. 2025 Jun 27:ciaf346. doi: 10.1093. PubMedAbstract available
COLLINS LF, Christopoulos KA, McNulty MC, Colasanti JA, et al Comparing interest in thigh administration of long-acting
cabotegravir/rilpivirine among hypothetical users, early adopters and trial
participants with experience.
Clin Infect Dis. 2025 Jun 25:ciaf333. doi: 10.1093. PubMed
TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A
Prospective Cohort Study.
Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093. PubMedAbstract available
PATAMATAMKUL S Should ART Be Interrupted in Recently Initiated Persons With Recently Diagnosed
HIV-Associated Cryptococcal Meningitis?
Clin Infect Dis. 2025 Jun 24:ciaf226. doi: 10.1093. PubMed
VAN ZYL GU, Decloedt E, Jennings L, Kellermann T, et al A real-time urine tenofovir assay improves drug adherence among people with HIV
with prior virologic failure in a randomized controlled trial.
Clin Infect Dis. 2025 Jun 20:ciaf337. doi: 10.1093. PubMedAbstract available
CORLEY MJ, Watanabe M, Pang APS, Dwaraka VB, et al Effect of Pitavastatin on Epigenetic Aging Biomarkers in People With HIV: Pilot
Substudy of the REPRIEVE Trial.
Clin Infect Dis. 2025 Jun 18:ciaf247. doi: 10.1093. PubMedAbstract available
LU X, Jiang Y, Zhang R, Zhang Y, et al Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of
Multidrug-Resistant Tuberculosis in Shanghai, China.
Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093. PubMedAbstract available
AGARWAL R, Nyendak M, Chava N, Allam RR, et al Long-term protection from TB preventive treatment among people with HIV in a
high-burden tuberculosis setting: an observational cohort study from India.
Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093. PubMedAbstract available
SHAPIRO L, Henao-Martinez AF Letter to the Editor: Re-evaluating Immune-Based Strategies for Cryptococcal
Meningitis in Non-HIV Populations.
Clin Infect Dis. 2025 Jun 16:ciaf326. doi: 10.1093. PubMed
HAW NJL, Lesko CR, Ng DK, Lam JO, et al Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV
after Transition to Adult HIV Care in the United States and Canada, 2000-2022.
Clin Infect Dis. 2025 Jun 5:ciaf300. doi: 10.1093. PubMedAbstract available
JAGANATH D, Nabeta P, Nicol MP, Castro R, et al Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A
prospective, multi-country accuracy study.
Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093. PubMedAbstract available
CROWELL TA, Hsieh HC, Agan BK New Data and Next Steps for Clarifying how the Timing of Antiretroviral Therapy
Initiation Influences Viral Blips and HIV Reservoir Size.
Clin Infect Dis. 2025 Jun 3:ciaf273. doi: 10.1093. PubMed
May 2025
AUDSLEY J, Avihingsanon A, Li X, Edwards R, et al Kinetics and predictors of Hepatitis B surface antigen (HBsAg) loss after
commencing HBV-active antiretroviral therapy (ART) in the setting of HIV-and
chronic HBV co-infection.
Clin Infect Dis. 2025 May 31:ciaf281. doi: 10.1093. PubMedAbstract available
PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al Risk of tuberculosis infection in young children exposed to multidrug-resistant
tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093. PubMedAbstract available
ANDREWS HS, Blanchard HL, Yang S, Utay NS, et al Low Rate of Documented Measles Immunity in a Large Urban HIV Clinic.
Clin Infect Dis. 2025 May 28:ciaf278. doi: 10.1093. PubMedAbstract available
HALL EW, Sandul AL, Kamili S, Cartwright EJ, et al Cost-Effectiveness Analysis of Testing Approaches for Diagnosis of Hepatitis C
Among US Adults.
Clin Infect Dis. 2025 May 21:ciaf166. doi: 10.1093. PubMedAbstract available
LOOSLI T, Moore CB, Buzaalirwa L, Byakwaga H, et al Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral
Therapy in Sub-Saharan Africa: The DTG RESIST Study.
Clin Infect Dis. 2025 May 20:ciaf204. doi: 10.1093. PubMedAbstract available
STURNY-LECLERE A, Francoise U, Badje AD, Garcia-Hermoso D, et al Histoplasma antigenuria prevalence in patients with advanced HIV disease in Cote
d'Ivoire: a prospective trial ancillary study.
Clin Infect Dis. 2025 May 16:ciaf237. doi: 10.1093. PubMedAbstract available
ODEYEMI Y, Tekin A, Schanz C, Schreier D, et al Comparative effectiveness of azithromycin versus doxycycline in hospitalized
patients with community acquired pneumonia treated with beta-lactams: A
multicenter matched cohort study.
Clin Infect Dis. 2025 May 16:ciaf252. doi: 10.1093. PubMedAbstract available
HAN WM, Ryom L, Sabin CA, Greenberg L, et al Risk of cancer in people with HIV experiencing varying degrees of immune recovery
with sustained virological suppression on antiretroviral treatment for more than
2 years: an international, multicentre, observational cohort.
Clin Infect Dis. 2025 May 15:ciaf248. doi: 10.1093. PubMedAbstract available
SCHWARTZ IS, Pasqualotto AC Histoplasma antigen screening in advanced HIV disease.
Clin Infect Dis. 2025 May 13:ciaf238. doi: 10.1093. PubMed
KONOPNICKI D, Gilles C, Manigart Y, Barlow P, et al Immunogenicity and safety of two versus three doses of 9-valent vaccine against
Human papillomavirus (HPV) in women with HIV: the Papillon randomized trial.
Clin Infect Dis. 2025 May 13:ciaf241. doi: 10.1093. PubMedAbstract available
HAWKINS KL, Dandachi D, Verzani Z, Brannock MD, et al HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based
Cohort Study.
Clin Infect Dis. 2025 May 12:ciaf242. doi: 10.1093. PubMedAbstract available
STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant
Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093. PubMedAbstract available
SPINELLI MA, Heise MJ, Roman J, Bena J, et al Sustained Effectiveness of Doxycycline Post-Exposure-Prophylaxis in a Large
Sexual Health Clinic over 96 Weeks: An Interrupted Time Series Analysis.
Clin Infect Dis. 2025 May 6:ciaf234. doi: 10.1093. PubMedAbstract available
NAMBIAR P, Liang T, Labo N, Hand J, et al Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and
Transplant Recipients with HIV in the United States.
Clin Infect Dis. 2025 May 5:ciaf229. doi: 10.1093. PubMedAbstract available
ZHU W, Delaney K, Huang YA, Patel RR, et al HIV RNA testing to monitor oral PrEP use does not add clinical value: a
real-world cohort study-United States, 2019-2023.
Clin Infect Dis. 2025 May 5:ciaf230. doi: 10.1093. PubMedAbstract available
April 2025
OMBAJO LA, Penner J, Nkuranga J, Omodi V, et al Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors
After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the
48-week Randomised Second-line Switch to Dolutegravir Trial.
Clin Infect Dis. 2025;80:889-892. PubMedAbstract available
HAO J, Liu X, Wang D, Hu H, et al Transmitted Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance Among
Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in
China in 2023: A Cross-sectional Survey.
Clin Infect Dis. 2025 Apr 29:ciaf159. doi: 10.1093. PubMedAbstract available
LARSSON L, Calderwood CJ, Marambire ET, Held K, et al Body mass index trajectories and association with tuberculosis risk in a cohort
of household contacts in Southern Africa.
Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093. PubMedAbstract available
GRINSPOON SK, Watanabe M, Ribaudo HJ, Bloomfield GS, et al Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People
with HIV.
Clin Infect Dis. 2025 Apr 25:ciaf210. doi: 10.1093. PubMedAbstract available
KRISHNAN S, Scully EP Untangling the Sources of HIV-related Cardiovascular Risk.
Clin Infect Dis. 2025 Apr 25:ciaf211. doi: 10.1093. PubMed
YOON H, Pirofski LA, Boulware DR Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for
Individualized Immune-Based Strategies.
Clin Infect Dis. 2025 Apr 25:ciaf218. doi: 10.1093. PubMedAbstract available
KIM S, Pelissari DM, Harada LO, Sanchez M, et al Long-term mortality trends among individuals with tuberculosis: a retrospective
cohort study of individuals diagnosed with tuberculosis in Brazil.
Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093. PubMedAbstract available
BREGER TL, Westreich DJ, Edmonds A, Edwards JK, et al Incidence of statin initiation among people with and without HIV in the US: a
prospective observational study.
Clin Infect Dis. 2025 Apr 17:ciaf207. doi: 10.1093. PubMedAbstract available
MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive
Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and
Pharmacogenetics.
Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093. PubMedAbstract available
KULIK GL, Mollner DC, Barbera L, Walker J, et al Application of Pragmatic Criteria to Assessments of Frailty and Physical Function
among People with HIV.
Clin Infect Dis. 2025 Apr 15:ciaf193. doi: 10.1093. PubMedAbstract available
SCOTT K, O'Rourke J, Jackson C, Ene L, et al Viral suppression, viral failure and safety outcomes in children and adolescents
living with HIV on dolutegravir in Europe and Thailand.
Clin Infect Dis. 2025 Apr 11:ciaf191. doi: 10.1093. PubMedAbstract available
BAETEN JM Lenacapavir for Human Immunodeficiency Virus (HIV) Prevention: A Commitment to
Equitable Access and Partnership by Gilead Sciences.
Clin Infect Dis. 2025 Apr 9:ciaf116. doi: 10.1093. PubMedAbstract available
HILL A, Siedner MJ, Fairhead C, Venter F, et al The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic.
Clin Infect Dis. 2025 Apr 9:ciaf115. doi: 10.1093. PubMedAbstract available
RIVERA-VILLEGAS H, Caro-Vega Y, Trujillo-Gamboa A, Lopez-Iniguez A, et al Differences in mortality in hospitalized advanced HIV disease between
treatment-naive and treatment-discontinuing individuals: a comparative
retrospective study from Mexico City.
Clin Infect Dis. 2025 Apr 3:ciaf175. doi: 10.1093. PubMedAbstract available
ZHU W, Delaney K, Huang YA, Patel RR, et al Real-world HIV RNA and antigen/antibody testing among people who use long-acting
injectable PrEP.
Clin Infect Dis. 2025 Apr 3:ciaf173. doi: 10.1093. PubMedAbstract available
WENSING AM, Charpentier C, Calvez V, Ceccherini-Silberstein F, et al Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance.
Clin Infect Dis. 2025 Apr 3:ciaf161. doi: 10.1093. PubMedAbstract available
DAVY-MENDEZ T, Napravnik S, Hogan BC, Eron JJ, et al Changes in the prevalence of non-AIDS conditions among hospitalized persons with
HIV in the United States and Canada, 2008-2018.
Clin Infect Dis. 2025 Apr 2:ciaf167. doi: 10.1093. PubMedAbstract available
STEAD D, Wasserman S, Steenkamp E, Parrish A, et al Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra
for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus
in East London, South Africa.
Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093. PubMedAbstract available
March 2025
GUARALDI G, Milic J A Metabolic Health Framework to Interpret Weight Gain Studies in People With
Human Immunodeficiency Virus.
Clin Infect Dis. 2025 Mar 28:ciae646. doi: 10.1093. PubMed
GARCIA-RUIZ DE MORALES AG, Suarez Robles M, Perez-Elias MJ, Negredo E, et al Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in
ART-naive Adults With Human Immunodeficiency Virus (HIV): A Multicenter
Prospective Cohort Study.
Clin Infect Dis. 2025 Mar 28:ciae645. doi: 10.1093. PubMedAbstract available
PEREZ-VALERO I, Mata DC, Espejo AC, Gallo M, et al Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other
regimens in people with HIV starting therapy with AIDS-defining conditions.
Results from the CORIS Cohort: The ACTUAS II Study.
Clin Infect Dis. 2025 Mar 27:ciaf162. doi: 10.1093. PubMedAbstract available
BARTL L, Zeeb M, Kalin M, Loosli T, et al Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using
Clinical Data.
Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093. PubMedAbstract available
ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in
Outpatients With Advanced HIV Disease.
Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093. PubMedAbstract available
MEYEROWITZ EA, Schwartz IS Silence=Death Redux: Infectious Diseases, Public Health, and the Imperative to
Resist.
Clin Infect Dis. 2025 Mar 24:ciaf155. doi: 10.1093. PubMedAbstract available
CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al Paucibacillary tuberculosis drives the low positive predictive value of Xpert
MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093. PubMedAbstract available
ROGG L, Underwood M, Hanan N, Castillo-Mancilla JR, et al Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer
Inhibitor With an Enhanced Resistance Profile.
Clin Infect Dis. 2025 Mar 21:ciaf135. doi: 10.1093. PubMedAbstract available
SODEKE O, Shah NS, Pals S, Riabokon S, et al Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who
Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden
Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093. PubMedAbstract available
MATOGA MM, Chen JS, Sena AC, Ndalama B, et al High prevalence of Haemophilus ducreyi among patients with suspected primary
syphilis in Malawi, 2019-2022.
Clin Infect Dis. 2025 Mar 17:ciaf114. doi: 10.1093. PubMedAbstract available
HASTIE E, Hill L, Bamford L, Karim A, et al Long-acting injectable HIV therapy outcomes among persons with HIV who have
adherence challenges to oral antiretroviral therapy.
Clin Infect Dis. 2025 Mar 17:ciaf120. doi: 10.1093. PubMedAbstract available
ROCKSTROH JK, Paredes R, Cahn P, Molina JM, et al Doravirine/islatravir (100/0.75 mg) once-daily compared to
bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment:
48-week results from a phase 3, randomized, controlled, double-blind,
non-inferiority trial.
Clin Infect Dis. 2025 Mar 13:ciaf077. doi: 10.1093. PubMedAbstract available
CHARPENTIER C, Berzow D, Le Hingrat Q, Kaiser R, et al HIV-2EU - Supporting Standardized HIV-2 Drug Resistance Interpretation: an
Update.
Clin Infect Dis. 2025 Mar 12:ciaf110. doi: 10.1093. PubMedAbstract available
VELAPHI S, Madewell ZJ, Tippett-Barr B, Blau DM, et al Investigating the role of cytomegalovirus as a cause of stillbirths and child
deaths in low and middle-income countries through postmortem minimally invasive
tissue sampling.
Clin Infect Dis. 2025 Mar 10:ciaf098. doi: 10.1093. PubMedAbstract available
CROWELL TA, Hsieh HC, Wang X, Chu X, et al Antiretroviral Therapy within Two Years of HIV Acquisition is Associated with
Fewer Viral Blips: A Retrospective Analysis of Over 20 Years of Data from the
U.S. Military HIV Natural History Study.
Clin Infect Dis. 2025 Mar 10:ciaf103. doi: 10.1093. PubMedAbstract available
DE MIGUEL R, de Lagarde Sebastian M, Blanco Arevalo JL, Pinto-Martinez A, et al Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons
with Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results
of a Single-Arm, Open-Label, Multicentre, Phase IIA Clinical Trial.
Clin Infect Dis. 2025 Mar 7:ciaf100. doi: 10.1093. PubMedAbstract available
February 2025
SOGE OO, Thibault CS, Cannon CA, McLaughlin SE, et al Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline
Resistance in Neisseria gonorrhoeae and Colonization with Tetracycline-Resistant
Staphylococcus aureus and Group A Streptococcus.
Clin Infect Dis. 2025 Feb 28:ciaf089. doi: 10.1093. PubMedAbstract available
BURGOS J, Curran A, Garcia J, Campany D, et al Effectiveness of electrocautery, topical cidofovir and topical sinecatechins for
the Treatment of Anal High-grade Squamous Intraepithelial Lesions in Persons with
HIV: an open-label, randomized controlled trial.
Clin Infect Dis. 2025 Feb 27:ciaf086. doi: 10.1093. PubMedAbstract available
VAN SICKELS N, Wong JWH, Villacorta-Cari E, Lee SE, et al State-of-the-Art Review: Data and Trust to Improve Care for Transgender and
Gender-Diverse Patients.
Clin Infect Dis. 2025;80:e16-e30. PubMedAbstract available
OKUMURA N, Morino E, Nomoto H, Yanagi M, et al LC16m8 for Pre-exposure Prophylaxis against Mpox in a High-Risk Population: An
Open-Label Randomized Trial.
Clin Infect Dis. 2025 Feb 21:ciaf074. doi: 10.1093. PubMedAbstract available
TZELIOS CA, Malatesta S, Carney T, White LF, et al Patient Determinants and Effects on Adherence of Adverse Drug Reactions to
Tuberculosis Treatment: A Prospective Cohort Analysis.
Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093. PubMedAbstract available
LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results
from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093. PubMedAbstract available
SAKURAI A, Ishikane M, Ohmagari N The Importance of Stratifying by Extremely Low CD4 Counts and Assessing Detailed
Clinical Information for Clear Outcome Measures.
Clin Infect Dis. 2025 Feb 7:ciaf058. doi: 10.1093. PubMed
BENDER IGNACIO R, Kitahata M, Montano M, Shapiro A, et al Mpox in People with HIV: Prioritizing Interventions for those without HIV Viral
Suppression.
Clin Infect Dis. 2025 Feb 7:ciaf059. doi: 10.1093. PubMed
TROYA J, Montes ML, Losa JE, Buzon-Martin L, et al Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the
Evidence.
Clin Infect Dis. 2025 Feb 5:ciaf024. doi: 10.1093. PubMed
COLLIER M, Chouchana L, Frange P, Sibiude J, et al Risk of Neurodevelopmental Disorders in Children Exposed to Human
Immunodeficiency Virus and Antiretrovirals In Utero: A National Cohort Study in
France.
Clin Infect Dis. 2025 Feb 5:ciae610. doi: 10.1093. PubMedAbstract available
GAISA M, Deshmukh A, Sigel K, Liu Y, et al 2024 Anal Cancer Screening Guidelines: Analysis of Clinical Performance and HRA
Utilization in a large Cohort of Persons with HIV.
Clin Infect Dis. 2025 Feb 3:ciaf052. doi: 10.1093. PubMedAbstract available
YU MA, Gerig L, Mehta CC, Musonge-Effoe J, et al Non-invasive markers of hepatic steatosis and fibrosis following INSTI initiation
in women with HIV.
Clin Infect Dis. 2025 Feb 3:ciaf049. doi: 10.1093. PubMedAbstract available
January 2025
GRENNAN T, Mohammed S, Edward J, Tattersall T, et al A pilot, randomized controlled trial of Dual Daily HIV and sexually transmitted
infection pre-exposure prophylaxis using tenofovir disoproxil
fumarate/emtricitabine and doxycycline in gay, bisexual and other men who have
sex with men and transgender w
Clin Infect Dis. 2025 Jan 30:ciaf043. doi: 10.1093. PubMedAbstract available
BILIR SP, Krishnamurthy P, Karichu JK, Blosser SJ, et al Estimating the economic consequences of leveraging the novel cobas(R) HIV-1/HIV-2
Qualitative NAT Test in routine HIV testing.
Clin Infect Dis. 2025 Jan 29:ciaf025. doi: 10.1093. PubMedAbstract available
CHEMALY RF, Shafat T, Wald A, Kotton CN, et al Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in
Immunocompromised Patients: Literature Review and Proposed Definitions for Use in
Clinical Trials.
Clin Infect Dis. 2025 Jan 29:ciae638. doi: 10.1093. PubMedAbstract available
FORD SL, Felizarta F, Han K, Wang K, et al Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With
Human Immunodeficiency Virus Type 1: A Substudy of the Phase 3b ATLAS-2M Study.
Clin Infect Dis. 2025 Jan 29:ciae620. doi: 10.1093. PubMedAbstract available
MARCUS JL, Weddle A, Kelley CF, Agwu A, et al Policy Recommendations to Support Equitable Access to Long-Acting Injectables for
Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the
Infectious Diseases Society of America and the HIV Medicine Association.
Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093. PubMedAbstract available
WONDMENEH S, McDonald R, Quilter LAS, Workowski K, et al Reported Neurologic Manifestations Among Persons with Syphilis by Stage of
Infection-12 States, 2019 -2022.
Clin Infect Dis. 2025 Jan 17:ciaf015. doi: 10.1093. PubMedAbstract available
KNUDSEN AD, Fuchs A, Benfield T, Kober L, et al HIV Is Associated With Subclinical Coronary Atherosclerosis: A Prospective
Matched Cohort Study.
Clin Infect Dis. 2025 Jan 16:ciae609. doi: 10.1093. PubMedAbstract available
BARRE T, Ramier C, Wittkop L, Sogni P, et al Low CD4 cell count is associated with post-hepatitis C virus cure mortality in
people living with HIV (ANRS CO13 HEPAVIH cohort).
Clin Infect Dis. 2025 Jan 15:ciaf016. doi: 10.1093. PubMed
MOYO M, Lawrence DS, Jafali J, Molloy SF, et al Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality
Risk in Human Immunodeficiency Virus-associated Cryptococcal Meningitis: An
Analysis of Clinical Trial Data From Africa.
Clin Infect Dis. 2025 Jan 15:ciae586. doi: 10.1093. PubMedAbstract available
MATELSKI A, Gregoire B, Beste LA, Varley CD, et al Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a
Large Cohort of U.S. Veterans.
Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093. PubMedAbstract available
Correction to: Prediction of HIV Drug Resistance Based on Virologic, Immunologic,
Clinical, and/or Adherence Criteria in the Stratall ANRS 12110/ESTHER Trial in
Cameroon.
Clin Infect Dis. 2025 Jan 7:ciaf001. doi: 10.1093. PubMed
PESONEL E, Laouenan C, Guiraud L, Bourner J, et al Clinical characterisation and outcomes of human clade IIb mpox virus disease - a
European multicentre observational cohort study (MOSAIC).
Clin Infect Dis. 2025 Jan 3:ciae657. doi: 10.1093. PubMedAbstract available
HUANG YS, Sun HY, Ho SY, Lin KY, et al Incidence and outcome of hepatitis D virus infection in people with HIV in the
era of tenofovir-containing antiretroviral therapy.
Clin Infect Dis. 2025 Jan 2:ciae655. doi: 10.1093. PubMedAbstract available
December 2024
MONTROUGE T, Bertine M, Peytavin G, Saint Joannis T, et al Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy with
Lenacapavir-Containing Regimen.
Clin Infect Dis. 2024 Dec 31:ciae650. doi: 10.1093. PubMedAbstract available
RUFFIEUX Y, Mwansa-Kambafwile J, Metekoua C, Tombe-Nyahuma T, et al HIV-1 Viremia and Cancer Risk in 2.8 Million People: the South African HIV Cancer
Match Study.
Clin Infect Dis. 2024 Dec 30:ciae652. doi: 10.1093. PubMedAbstract available
PEREZ NAVARRO A, Nutt CT, Siedner MJ, McCluskey SM, et al Virologic failure and emergent integrase strand transfer inhibitor drug
resistance with long acting cabotegravir for HIV treatment: A meta-analysis.
Clin Infect Dis. 2024 Dec 26:ciae631. doi: 10.1093. PubMedAbstract available
HAN WM, Solomon S, Smeaton L, Avihingsanon A, et al Reinfection and resistance associated substitutions following a minimal
monitoring approach for HCV treatment in MINMON trial.
Clin Infect Dis. 2024 Dec 20:ciae627. doi: 10.1093. PubMedAbstract available
COUSSEMENT J, Heath CH, Roberts MB, Lane RJ, et al Management, outcomes and predictors of mortality of Cryptococcus infection in
patients without HIV: a multicentre study in 46 hospitals from Australia and New
Zealand.
Clin Infect Dis. 2024 Dec 18:ciae630. doi: 10.1093. PubMedAbstract available
BJORNSON AM, Bedimo RJ, Szabo SM, Rochon H, et al Morbidity and Mortality Risk Among People With Human Immunodeficiency Virus and
Central or Visceral Adiposity: A Targeted Literature Review.
Clin Infect Dis. 2024 Dec 18:ciae543. doi: 10.1093. PubMedAbstract available
EPLING BP, Lisco A, Manion M, Laidlaw E, et al Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With
Advanced Human Immunodeficiency Virus.
Clin Infect Dis. 2024 Dec 18:ciae562. doi: 10.1093. PubMedAbstract available
KHAN U, Rich M, Franke M, Lachenal N, et al The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline
or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093. PubMedAbstract available
KAMKWALALA AR, Matthews A, Garg A, Roy U, et al The Effects of Prescribed Medications on Depressive Symptoms and Neurocognitive
Performance in People With Human Immunodeficiency Virus (HIV).
Clin Infect Dis. 2024 Dec 10:ciae518. doi: 10.1093. PubMedAbstract available
PINANA JL, Carbonell-Asins JA, Gomez D, Montoro J, et al Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors
after Allogeneic Stem Cell Transplant?
Clin Infect Dis. 2024 Dec 5:ciae602. doi: 10.1093. PubMedAbstract available
SWINDELLS S Bookends.
Clin Infect Dis. 2024 Dec 5:ciae554. doi: 10.1093. PubMed
November 2024
MAGUIRE C, Rueve K, Farmer E, Huesgen E, et al Real world virologic outcomes in patients with elevated body mass index receiving
long acting cabotegravir/rilpivirine.
Clin Infect Dis. 2024 Nov 27:ciae579. doi: 10.1093. PubMedAbstract available
FAUCI AS, Folkers GK HIV/AIDS and COVID-19: Shared Lessons from Two Pandemics.
Clin Infect Dis. 2024 Nov 27:ciae585. doi: 10.1093. PubMedAbstract available
MOUNZER K, Slim J, Ramgopal M, Hedgcock M, et al Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a
Complex Human Immunodeficiency Virus Treatment Regimen: A Randomized, Open-Label,
Multicenter Phase 2 Study (ARTISTRY-1).
Clin Infect Dis. 2024 Nov 26:ciae522. doi: 10.1093. PubMedAbstract available
CLEMENT ME, Hanscom B, Haines D, Bazan JA, et al Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A
Secondary Analysis of HPTN 083.
Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093. PubMedAbstract available
LANZ C, Meier J, Stockle M, Furrer H, et al HIV-1 low-level viremia predicts viral failure in participants on antiretroviral
therapy in the Swiss HIV Cohort Study.
Clin Infect Dis. 2024 Nov 21:ciae569. doi: 10.1093. PubMedAbstract available
PUYAT JH, Brode SK, Shulha H, Romanowski K, et al Predicting risk of tuberculosis disease in people migrating to a low-TB incidence
country: development and validation of a multivariable dynamic risk prediction
model using health administrative data.
Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093. PubMedAbstract available
ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency
Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093. PubMedAbstract available
DAVIS JM, Rana A, Sax PE, Bares SH, et al Long-Acting Cabotegravir Plus Rilpivirine in People with HIV with Adherence
Challenges and Viremia: Current Data and Future Directions.
Clin Infect Dis. 2024 Nov 12:ciae557. doi: 10.1093. PubMedAbstract available
PU J, Wu S, He JQ Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive
Patients with Tuberculosis: a systematic review and meta-analysis of randomized
controlled trials.
Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093. PubMedAbstract available
JANI IV, Sabi I, Elsbernd K, Meggi B, et al Impact of point-of-care birth test-and-treat on clinical outcomes among infants
with HIV: A cluster randomized trial in Mozambique and Tanzania.
Clin Infect Dis. 2024 Nov 8:ciae530. doi: 10.1093. PubMedAbstract available
LUO Q, Horner MJ, Haas CB, McGee-Avila JK, et al Differences in Trends in Cancer Incidence Rates Among People with HIV during
2001-2019 By Race and Ethnicity and By Risk Group in the United States.
Clin Infect Dis. 2024 Nov 7:ciae555. doi: 10.1093. PubMedAbstract available
DE WAAL R, Wools-Kaloustian K, Brazier E, Althoff KN, et al Global trends in CD4 count measurement and distribution at first antiretroviral
treatment initiation.
Clin Infect Dis. 2024 Nov 6:ciae548. doi: 10.1093. PubMedAbstract available
ABELMAN RA, Ma Y, Mehta CC, Yang Q, et al Switch to Integrase Strand Transfer Inhibitors during the Menopausal Transition
is Associated with Accelerated Body Composition Change in Women with HIV.
Clin Infect Dis. 2024 Nov 4:ciae540. doi: 10.1093. PubMedAbstract available
ACHHRA AC, Chan E, Applebaum S, Guerrero M, et al Five-year evaluation of Anal Cancer Screening Program in Men Who Have Sex With
Men with HIV at Two Academic Center Clinics.
Clin Infect Dis. 2024 Nov 4:ciae541. doi: 10.1093. PubMedAbstract available
SPINELLI MA, Bisom-Rapp E, Heise MJ, Camp C, et al High Retention and Adherence with Rapid Long-Acting Injectable PrEP
Implementation in an Urban Safety-Net Clinic Population.
Clin Infect Dis. 2024 Nov 1:ciae531. doi: 10.1093. PubMedAbstract available
October 2024
DOMBROWSKI JC, Donnell D, Grabow C, Cohen SE, et al Evidence-Informed Provision of Doxycycline Post-Exposure Prophylaxis for
Prevention of Bacterial Sexually Transmitted Infections.
Clin Infect Dis. 2024 Oct 30:ciae527. doi: 10.1093. PubMedAbstract available
ORKIN C, Hayes R, Haviland J, Wong YL, et al Perspectives of people with HIV on implementing long acting cabotegravir plus
rilpivirine in clinics and community settings in the UK: results from the
anti-sexist, anti-racist, anti-ageist ILANA study.
Clin Infect Dis. 2024 Oct 28:ciae523. doi: 10.1093. PubMedAbstract available
HORBERG M, Thompson M, Agwu A, Colasanti J, et al Primary Care Guidance for Providers of Care for Persons With Human
Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the
Infectious Diseases Society of America.
Clin Infect Dis. 2024 Oct 12:ciae479. doi: 10.1093. PubMedAbstract available
VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al Risk of tuberculosis after achieving HIV virological suppression on
antiretroviral therapy: a Danish nationwide prospective cohort study.
Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093. PubMedAbstract available
MONTANO M, Shapiro AE, Whitney BM, Bamford L, et al Mpox in People With Human Immunodeficiency Virus: Predictors of Diagnosis,
Outcomes, and Vaccine Effectiveness in a Multisite Cohort.
Clin Infect Dis. 2024 Oct 8:ciae464. doi: 10.1093. PubMedAbstract available
KIRK SE, Young C, Berry H, Hanson R, et al Comparison of At-Home Versus In-Clinic Receipt of Long-Acting Injectable
Cabotegravir/Rilpivirine.
Clin Infect Dis. 2024 Oct 8:ciae472. doi: 10.1093. PubMedAbstract available
HICKEY MD, Gistand N, Grochowski J, Mayorga-Munoz F, et al 48-week viral suppression rates in people with HIV starting long-acting CAB/RPV
with initial viremia.
Clin Infect Dis. 2024 Oct 5:ciae500. doi: 10.1093. PubMedAbstract available
INZAULE S, Easterbrook P, Latona A, Ford NP, et al Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic
Hepatitis C Infection and Virological Failure Following Initial or Re-treatment
With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and
Meta-analysis.
Clin Infect Dis. 2024 Oct 3:ciae431. doi: 10.1093. PubMedAbstract available
September 2024
ROTH AM, Bartholomew TS, Ward KM, Groves A, et al Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure
Prophylaxis Among Women Who Inject Drugs.
Clin Infect Dis. 2024 Sep 30:ciae450. doi: 10.1093. PubMedAbstract available
FAIRHEAD C, Levi J, Ramesh N, Hill A, et al Results from systematic review and meta-analysis of the efficacy and safety of
two-drug versus three-drug ( Tenofovir/Lamivudine/Dolutegravir; TLD) regimens for
HIV treatment.
Clin Infect Dis. 2024 Sep 30:ciae490. doi: 10.1093. PubMed
FONG Y, Dang L, Zhang B, Fintzi J, et al Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the
COVAIL Trial.
Clin Infect Dis. 2024 Sep 26:ciae465. doi: 10.1093. PubMedAbstract available
LAHIRI CD, Mehta CC, Yang Q, Maramba T, et al "Short and Long-term Body Weight Change Following the Switch to or the Addition
of Integrase Inhibitors in Persons with HIV Differs by Sex".
Clin Infect Dis. 2024 Sep 26:ciae474. doi: 10.1093. PubMedAbstract available
BEDIMO R, Hardy D, Lee D, Palella F, et al Expert Consensus Statement on an Updated Definition of Unintended Weight Loss
Among Persons With Human Immunodeficiency Virus in the Modern Treatment Era.
Clin Infect Dis. 2024;79. PubMedAbstract available
GUTIERREZ F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al Virological History Predicts Non-sustained Viral Suppression with Long-Acting
Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters.
Clin Infect Dis. 2024 Sep 19:ciae475. doi: 10.1093. PubMedAbstract available
MARTIN-CARMONA J, Corma-Gomez A, Tellez F, Arenga-Barrios D, et al No impact of HIV coinfection on the mortality in patients with hepatitis C virus
infection after sustained virological response.
Clin Infect Dis. 2024 Sep 18:ciae473. doi: 10.1093. PubMedAbstract available
JOLY V, Ferre VM, Le Hingrat Q, Peytavin G, et al Immuno-virological and Clinical Follow-up of Persons Living With HIV-2 (PWHIV-2)
Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate (BIC/FTC/TAF):
A Retrospective Study.
Clin Infect Dis. 2024 Sep 16:ciae447. doi: 10.1093. PubMedAbstract available
VIDAL JE, Duarte AN, Chow FC, Duarte MIS, et al Does "Toxoplasma abscess" Properly Describe Brain Lesions Caused by Toxoplasma
gondii?
Clin Infect Dis. 2024 Sep 9:ciae463. doi: 10.1093. PubMed
ANDERSON D, Ramgopal M, Hagins DP, Lee J, et al DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease
Inhibitor-based Regimen Switch Strategy to Manage Integrase Inhibitor-related
Weight Gain.
Clin Infect Dis. 2024 Sep 4:ciae449. doi: 10.1093. PubMedAbstract available
EKE AC, Brummel SS, Aliyu MH, Stranix-Chibanda L, et al Lipid and glucose profiles in pregnant women with HIV on tenofovir-based
antiretroviral therapy.
Clin Infect Dis. 2024 Sep 2:ciae441. doi: 10.1093. PubMedAbstract available
August 2024
GROENENDIJK AL, Miranda Afonso P, Wit F, Blaauw MJT, et al The risk of non-AIDS defining events is lower in ART-naive HIV controllers than
in normal progressors on suppressive ART.
Clin Infect Dis. 2024 Aug 29:ciae440. doi: 10.1093. PubMedAbstract available
OGBUAGU O, Molina JM, Chetchotisakd P, Ramgopal MN, et al Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily
Treatment-Experienced People with Multi-Drug Resistant HIV-1: Week 104 Results of
a Phase 2/3 Trial.
Clin Infect Dis. 2024 Aug 29:ciae423. doi: 10.1093. PubMedAbstract available
BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as
Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093. PubMedAbstract available
GAKURU J, Kagimu E, Dai B, Okurut S, et al Implementation of single high-dose liposomal amphotericin B based induction
therapy for treatment of HIV-associated cryptococcal meningitis in Uganda: a
comparative prospective cohort study.
Clin Infect Dis. 2024 Aug 24:ciae413. doi: 10.1093. PubMedAbstract available
ERLANDSON KM, Umbleja T, Ribaudo HJ, Schrack JA, et al Pitavastatin is Well-Tolerated with no Detrimental Effects on Physical Function.
Clin Infect Dis. 2024 Aug 19:ciae422. doi: 10.1093. PubMedAbstract available
BERTHAUD V, Creech CB, Rostad CA, Carr Q, et al Safety and Immunogenicity of an mRNA-1273 Booster in Children.
Clin Infect Dis. 2024 Aug 19:ciae420. doi: 10.1093. PubMedAbstract available
GRISEL B, Kaur K, Swain S, Gorenshtein L, et al The Ethical Obligation to Treat Infectious Patients: A Systematic Review of
Reasons.
Clin Infect Dis. 2024;79:339-347. PubMedAbstract available
RUPASINGHE D, Bansi-Matharu L, Law M, Zangerle R, et al Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of
diabetes: a prospective study from the RESPOND cohort consortium.
Clin Infect Dis. 2024 Aug 9:ciae406. doi: 10.1093. PubMedAbstract available
July 2024
FRIEDMAN JR, Abramovitz D, Skaathun B, Rangel G, et al Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject
Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
Clin Infect Dis. 2024 Jul 30:ciae372. doi: 10.1093. PubMedAbstract available
BAI AD, Srivastava S, Martinez Cajas JL, Razak F, et al Community-acquired pneumonia in people with Human Immunodeficiency Virus (HIV)
during the current era of effective antiretroviral therapy: A multi-center
retrospective cohort study.
Clin Infect Dis. 2024 Jul 27:ciae393. doi: 10.1093. PubMedAbstract available
DITZENBERGER GL, Lake JE, Kitch DW, Kantor A, et al Effects of Semaglutide on Muscle Structure and Function in the SLIM LIVER Study.
Clin Infect Dis. 2024 Jul 24:ciae384. doi: 10.1093. PubMedAbstract available
HIRUY H, Bala S, Byrne JM, Roche KG, et al FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations
of Antimicrobial Drugs for the Treatment of Gonorrhea.
Clin Infect Dis. 2024 Jul 24:ciae386. doi: 10.1093. PubMedAbstract available
MEYA DB, Nalintya E, Skipper CP, Kirumira P, et al Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis
in People With Human Immunodeficiency Virus (HIV)-Associated Cryptococcal
Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers.
Clin Infect Dis. 2024 Jul 24:ciae266. doi: 10.1093. PubMedAbstract available
KAUPPINEN KJ, Aho I, Sjoblom N, Tynninen O, et al Effect of Two Forms of Tenofovir on Duodenal Enterocytes - a Hypothesis for
Different Effect of TDF and TAF on Body Weight and Plasma Lipids.
Clin Infect Dis. 2024 Jul 23:ciae374. doi: 10.1093. PubMedAbstract available
JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the
Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With
Human Immunodeficiency Virus in the North West Province of South Africa (the Teko
Study): A Cl
Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093. PubMedAbstract available
SWARTZ TH, Aberg JA Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating
Financial and Regulatory Landscapes.
Clin Infect Dis. 2024;79:272-273. PubMed
FIERER DS, Carollo JR, Rodriguez-Caprio G, Radix A, et al Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New
York City.
Clin Infect Dis. 2024 Jul 18:ciae297. doi: 10.1093. PubMedAbstract available
JILG N, Giganti MJ, Chew KW, Shaw-Saliba K, et al Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid
Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019.
Clin Infect Dis. 2024 Jul 17:ciae324. doi: 10.1093. PubMedAbstract available
FAIRHEAD C, Levi J, Hill A Challenges for novel antiretroviral development in an era of widespread TLD
availability.
Clin Infect Dis. 2024 Jul 11:ciae361. doi: 10.1093. PubMedAbstract available
GUTIERREZ F, Lopez L, Galera C, Tiraboschi JM, et al Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a
Comprehensive Cancer Screening Protocol.
Clin Infect Dis. 2024 Jul 3:ciae359. doi: 10.1093. PubMedAbstract available
MOHAREB AM, Barshak MB, Papaliodis GN, Sobrin L, et al Ocular syphilis in patients with nonreactive RPR and positive treponemal
serologies: a retrospective observational cohort study.
Clin Infect Dis. 2024 Jul 2:ciae354. doi: 10.1093. PubMedAbstract available
June 2024
KIMUDA S, Kwizera R, Dai B, Kigozi E, et al Comparison of early fungicidal activity and mortality between daily liposomal
amphotericin B and daily amphotericin B deoxycholate among patients with
HIV-associated cryptococcal meningitis.
Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093. PubMedAbstract available
COLLINS LF, Sheth AN, Tisdale T, Mehta CC, et al Interest in and Preference for Long-acting Injectable Antiretroviral Therapy in
the Era of Approved Cabotegravir/Rilpivirine among Reproductive-aged Women in the
U.S. South.
Clin Infect Dis. 2024 Jun 29:ciae331. doi: 10.1093. PubMedAbstract available
FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study
Comparison from Two Large, Open-Label Studies.
Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093. PubMedAbstract available
BORRE ED, Ahonkhai AA, Chi KK, Osman A, et al Projecting the Potential Clinical and Economic Impact of Human Immunodeficiency
Virus Prevention Resource Reallocation in Tennessee.
Clin Infect Dis. 2024 Jun 24:ciae243. doi: 10.1093. PubMedAbstract available
BROWN L, Rautemaa-Richardson R, Mengoli C, Alanio A, et al Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised
Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and
Meta-analysis.
Clin Infect Dis. 2024 Jun 11:ciae239. doi: 10.1093. PubMedAbstract available
TAO G, Patel CG, He L, Workowski K, et al STI/HIV testing, STIs, and HIV PrEP use among men who have sex with men (MSM) and
men who have sex with men and women (MSMW) in United States, 2019-2022.
Clin Infect Dis. 2024 Jun 10:ciae314. doi: 10.1093. PubMedAbstract available
SKRIVANKOVA VW, Huwa J, Muula G, Chiwaya GD, et al Virologic Failure and Drug Resistance After Programmatic Switching to
Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
Clin Infect Dis. 2024 Jun 7:ciae261. doi: 10.1093. PubMedAbstract available
ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural
Uganda.
Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093. PubMedAbstract available
May 2024
ALEXANDRE M, Prague M, Lhomme E, Lelievre JD, et al Definition of Virological Endpoints Improving the Design of Human
Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral
Treatment Interruption.
Clin Infect Dis. 2024 May 31:ciae235. doi: 10.1093. PubMedAbstract available
WEDDLE A Position of the Infectious Diseases Society of America and the HIV Medicine
Association on Team-Based Infectious Diseases Care and the Roles of Advanced
Practice Providers and Clinical Pharmacists.
Clin Infect Dis. 2024 May 27:ciae265. doi: 10.1093. PubMed
SAX PE Team-Based HIV Care is the Best Care.
Clin Infect Dis. 2024 May 24:ciae264. doi: 10.1093. PubMed
KONU YR, Takassi E, Peytavin G, Dapam N, et al Pharmaco-virological outcomes and genotypic resistance profiles among children
and adolescents receiving a DTG-based regimen in Togo.
Clin Infect Dis. 2024 May 15:ciae278. doi: 10.1093. PubMedAbstract available
BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in
adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093. PubMedAbstract available
UNIGWE I, Goodin A, Lo-Ciganic WH, Cook RL, et al Trajectories of Pre-exposure Prophylaxis Adherence Among Commercially Insured
Individuals.
Clin Infect Dis. 2024;78:1272-1275. PubMedAbstract available
CARLUCCI JG, Huntington T, Technau KG, Yotebieng M, et al High Prevalence of Unconfirmed Positive HIV PCR Test Results among African
Infants with HIV Exposure in the International epidemiology Databases to Evaluate
AIDS (IeDEA) Consortium.
Clin Infect Dis. 2024 May 14:ciae251. doi: 10.1093. PubMedAbstract available
SHAH NS, Kityo C, Hughes MD, McCarthy C, et al Effectiveness of double-dose dolutegravir in people receiving rifampin-based
tuberculosis treatment: an observational, cohort study of people with HIV from
six countries.
Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093. PubMedAbstract available
NYEIN PP, Petoumenos K, Borok M, Eriobu N, et al Associations between antiretroviral regimen and changes in blood pressure:
results from the D2EFT study.
Clin Infect Dis. 2024 May 9:ciae256. doi: 10.1093. PubMedAbstract available
SUN C, Yang Z, Wen Y Current knowledge about long-term liver outcome among HBV/HIV coinfected
patients.
Clin Infect Dis. 2024 May 7:ciae247. doi: 10.1093. PubMed
VINIKOOR MJ, Lauer GM People with HBV/HIV coinfection should be prioritized in HBV cure research.
Clin Infect Dis. 2024 May 7:ciae248. doi: 10.1093. PubMed
SHORT WR, Zimmerman MM, Mohamed O, Mofenson LM, et al Safety Data Timelines for Pregnant Individuals with HIV on Antiretroviral
Therapy.
Clin Infect Dis. 2024 May 6:ciae249. doi: 10.1093. PubMedAbstract available
ZHANG HL, Mock M, Bushman L, Anderson PL, et al Cumulative tenofovir exposure among patients with human immunodeficiency
virus/hepatitis B co-infection with differential viral suppression.
Clin Infect Dis. 2024 May 3:ciae241. doi: 10.1093. PubMedAbstract available
VAN DER WEKKEN-PAS L, Weiss F, Simon-Zuber C, Sebisch R, et al Cabotegravir and rilpivirine long acting injectables in a pregnant woman living
with HIV.
Clin Infect Dis. 2024 May 3:ciae242. doi: 10.1093. PubMedAbstract available
April 2024
HOLT LM, Short WR, Momplaisir F, Hyun E, et al Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis
Evaluating HIV Viral Suppression and Perinatal Outcomes.
Clin Infect Dis. 2024 Apr 26:ciae218. doi: 10.1093. PubMedAbstract available
TUSCH E, Ryom L, Pelchen-Matthews A, Mocroft A, et al Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort
collaboration.
Clin Infect Dis. 2024 Apr 26:ciae228. doi: 10.1093. PubMedAbstract available
ROSENBERG NE, Shook-Sa BE, Young AM, Zou Y, et al An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled
analysis across 15 nationally representative surveys.
Clin Infect Dis. 2024 Apr 24:ciae211. doi: 10.1093. PubMedAbstract available
MWESIGWA B, Sawe F, Oyieko J, Mwakisisile J, et al Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine
Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis. 2024 Apr 24:ciae215. doi: 10.1093. PubMedAbstract available
COYLE RP, Morrow M, Mann SC, Mainella V, et al Tenofovir-Diphosphate and Emtricitabine-Triphosphate Adherence Benchmarks in
Dried Blood Spots for Persons with HIV Receiving Tenofovir Alafenamide and
Emtricitabine-based Antiretroviral Therapy (QUANTI-TAF).
Clin Infect Dis. 2024 Apr 18:ciae212. doi: 10.1093. PubMedAbstract available
WOHL DA, Koethe JR, Sax PE, McComsey GA, et al Antiretrovirals and Weight Change: Weighing the Evidence.
Clin Infect Dis. 2024 Apr 12:ciae191. doi: 10.1093. PubMedAbstract available
DAMAS J, Munting A, Fellay J, Haerry D, et al Weight, anthropometric and metabolic changes after discontinuing antiretroviral
therapy containing tenofovir alafenamide (TAF) in people with HIV.
Clin Infect Dis. 2024 Apr 12:ciae189. doi: 10.1093. PubMedAbstract available
HILL A Which form of tenofovir should be used worldwide: TDF or TAF?
Clin Infect Dis. 2024 Apr 12:ciae190. doi: 10.1093. PubMed
SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al COVID-19 vaccine efficacy in participants with weakened immune systems from four
randomized-controlled trials.
Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093. PubMedAbstract available
BACHELARD A, Le Hingrat Q, Ferre VM, Le M, et al Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human
Immunodeficiency Virus Type 2 Infection.
Clin Infect Dis. 2024;78:1005-1010. PubMedAbstract available
CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al Clinical outcomes in children living with HIV treated for non-severe tuberculosis
in the SHINE Trial.
Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093. PubMedAbstract available
CACHAY ER, Gilbert T, Qin H, Mathews WC, et al Clinical Predictors and Outcomes of Invasive Anal Cancer for People With Human
Immunodeficiency Virus in an Inception Cohort.
Clin Infect Dis. 2024 Apr 4:ciae124. doi: 10.1093. PubMedAbstract available
RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al Tuberculosis disease in immunocompromised children and adolescents: a pTBnet
multi-centre case-control study.
Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093. PubMedAbstract available
PODANY AT, Cramer Y, Imperial M, Rosenkranz SL, et al Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily
Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis. 2024 Apr 3:ciae183. doi: 10.1093. PubMedAbstract available
TSCHUMI N, Lukau B, Tlali K, Motaboli L, et al Emergence of acquired dolutegravir resistance in treatment-experienced people
with HIV in Lesotho.
Clin Infect Dis. 2024 Apr 3:ciae185. doi: 10.1093. PubMedAbstract available
FAHERTY EAG, Holly T, Ogale YP, Spencer H, et al Investigation of an mpox outbreak affecting many vaccinated persons in Chicago,
IL-March 2023-June 2023.
Clin Infect Dis. 2024 Apr 3:ciae181. doi: 10.1093. PubMedAbstract available
March 2024
ROSTAD CA, Atmar RL, Walter EB, Frey S, et al A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and
Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017
A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03
Adjuvant in Healthy US
Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093. PubMedAbstract available
BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B
Infection-California, 2016-2020.
Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093. PubMedAbstract available
JAO J, Bonner LB, Dobinda K, Powis KM, et al Lower Insulin Sensitivity Through 36 Months of Life With in Utero HIV and
Antiretroviral Exposure in Botswana: Results From the Tshilo Dikotla Study.
Clin Infect Dis. 2024 Mar 26:ciae088. doi: 10.1093. PubMedAbstract available
VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on
Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093. PubMedAbstract available
BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
Clin Infect Dis. 2024;78:554-561. PubMedAbstract available
KRISHNAN S, Chaisson RE US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
Clin Infect Dis. 2024;78:514-517. PubMedAbstract available
VANBAELEN T, Tsoumanis A, Kenyon C Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts
and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
Clin Infect Dis. 2024;78:803-805. PubMed
NGUYEN Q, Wooten D, Lee D, Moreno M, et al GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093. PubMedAbstract available
HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its
well-Informed implementation.
Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093. PubMed
KENYON C We should not downplay the risks that doxycycline PEP will select for AMR.
Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093. PubMed
LANDOVITZ RJ, Tao L, Yang J, de Boer M, et al HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis:
Pooled Analysis From 72 Global Studies.
Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093. PubMedAbstract available
MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al The positioning of ceftobiprole in the treatment of Staphylococcus aureus
bacteremia.
Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093. PubMed
NGO HX, Xu AY, Velasquez GE, Zhang N, et al Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support
Flat-Dosing of Rifampicin for Tuberculosis.
Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093. PubMedAbstract available
February 2024
CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093. PubMed
TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al Long-term protective effect of tuberculosis preventive therapy in a medium/high
TB incidence setting.
Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093. PubMedAbstract available
SALDANA CS, Burkhardt E, Pennisi A, Oliver K, et al Development of a Machine Learning Modelling Tool for Predicting HIV Incidence
Using Public Health Data from a County in the Southern United States.
Clin Infect Dis. 2024 Feb 23:ciae100. doi: 10.1093. PubMedAbstract available
FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al Durability of Protection Against COVID-19 Through the Delta Surge for the
NVX-CoV2373 Vaccine.
Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093. PubMedAbstract available
January 2024
LITWIN AH, Akiyama MJ US Veterans Health Administration Hepatitis C Virus (HCV) Program - A Model for
National HCV Elimination though Patient-Centered Medical Homes.
Clin Infect Dis. 2024 Jan 27:ciae028. doi: 10.1093. PubMed
YATES TA, Halliday N Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of
Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV
Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver
Transplant Reci
Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093. PubMed
November 2023
HERBERT C, Manabe YC, Filippaios A, Lin H, et al Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2
Infection: Results from a Longitudinal Cohort Study.
Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093. PubMedAbstract available
September 2022
BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al Infectious Diseases Society of America Guidelines on the Treatment and Management
of Patients with COVID-19.
Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093. PubMedAbstract available